Globalspace Technologies Ltd

Globalspace Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Globalspace Technologies Ltd

₹ 24.0 1.52%
21 Jul - close price
globalspace.in BSE: 540654
About

Incorporated in 2010, Globalspace Technologies Ltd is in the business of providing technology enabled solutions and allied activities.[1]

Key Points

Business Overview:[1][2]
GSTL is an AI-powered healthcare ecosystem integrating digital health and pharma tech for patients, providers, and pharmaceutical companies. It also provides customized software solutions and technology-enabled business enhancement services across the IT and communication industry.

Website BSE
  • Market Cap ₹ 82.5 Cr.
  • Current Price ₹ 24.0
  • High / Low ₹ 33.5 / 13.7
  • Stock P/E 29.0
  • Book Value ₹ 16.6
  • Dividend Yield 0.00 %
  • ROCE 4.55 %
  • ROE 5.13 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 47.9 to 32.0 days.
  • Company's working capital requirements have reduced from 153 days to 77.0 days

Cons

  • Company has a low return on equity of 2.37% over last 3 years.
  • Contingent liabilities of Rs.36.4 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Information Technology Information Technology IT - Software Computers - Software & Consulting

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Jun 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
4.52 2.18 5.94 9.50 4.70 10.03 11.57 12.69 8.75 8.78 10.01 16.64 16.04
0.62 1.17 4.53 8.23 4.12 9.60 10.53 11.22 7.96 7.97 8.87 15.07 15.27
Operating Profit 3.90 1.01 1.41 1.27 0.58 0.43 1.04 1.47 0.79 0.81 1.14 1.57 0.77
OPM % 86.28% 46.33% 23.74% 13.37% 12.34% 4.29% 8.99% 11.58% 9.03% 9.23% 11.39% 9.44% 4.80%
0.00 0.03 0.04 0.02 -3.91 -2.76 0.02 0.02 0.01 0.01 0.01 0.01 0.37
Interest 1.11 0.54 0.57 0.34 0.31 0.31 0.25 0.32 0.21 0.24 0.23 0.19 0.21
Depreciation 0.46 1.02 1.01 0.74 0.79 0.56 0.53 0.50 0.76 0.43 0.53 0.45 0.45
Profit before tax 2.33 -0.52 -0.13 0.21 -4.43 -3.20 0.28 0.67 -0.17 0.15 0.39 0.94 0.48
Tax % 5.58% 1.92% 30.77% 0.00% -8.80% -19.69% 78.57% 0.00% -11.76% -13.33% 130.77% 61.70% -412.50%
2.20 -0.54 -0.17 0.21 -4.04 -2.57 0.06 0.67 -0.15 0.16 -0.12 0.36 2.45
EPS in Rs 0.64 -0.16 -0.05 0.06 -1.18 -0.75 0.02 0.19 -0.04 0.05 -0.03 0.10 0.71
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
15.34 25.91 27.09 13.29 29.05 43.05 51.47
9.03 19.21 16.79 6.39 24.25 39.33 47.16
Operating Profit 6.31 6.70 10.30 6.90 4.80 3.72 4.31
OPM % 41.13% 25.86% 38.02% 51.92% 16.52% 8.64% 8.37%
0.17 0.01 0.09 0.05 -3.74 -2.71 0.39
Interest 0.84 0.87 0.91 1.54 1.76 1.09 0.88
Depreciation 3.64 1.48 2.28 4.48 3.11 2.35 1.87
Profit before tax 2.00 4.36 7.20 0.93 -3.81 -2.43 1.95
Tax % 42.50% 31.65% 20.97% 25.81% -7.35% -17.28% -46.15%
1.15 2.97 5.68 0.69 -3.53 -2.00 2.85
EPS in Rs 0.33 0.93 1.65 0.16 -1.03 -0.58 0.83
Dividend Payout % 0.00% 0.00% 4.05% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: %
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: -13%
3 Years: %
TTM: 265%
Stock Price CAGR
10 Years: %
5 Years: -6%
3 Years: 13%
1 Year: 54%
Return on Equity
10 Years: %
5 Years: %
3 Years: 2%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
Equity Capital 11.46 11.46 11.46 11.46 34.37 34.37 34.37
Reserves 22.12 18.14 24.12 23.78 22.04 19.89 22.58
4.44 7.64 10.34 28.14 12.58 9.69 2.79
3.02 6.15 7.66 4.60 1.47 4.51 7.04
Total Liabilities 41.04 43.39 53.58 67.98 70.46 68.46 66.78
10.76 8.95 15.98 25.60 20.14 11.80 36.78
CWIP 1.29 1.96 0.99 1.41 1.98 12.16 0.00
Investments 0.00 0.00 0.00 0.00 1.01 1.01 1.01
28.99 32.48 36.61 40.97 47.33 43.49 28.99
Total Assets 41.04 43.39 53.58 67.98 70.46 68.46 66.78

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
-19.94 0.61 7.88 -2.35 -10.49 7.89 21.83
-2.77 -3.22 -8.25 -14.48 -3.86 -4.19 -14.69
5.18 2.33 2.43 14.64 14.34 -3.42 -7.28
Net Cash Flow -17.52 -0.28 2.06 -2.18 0.00 0.28 -0.13
Free Cash Flow -22.52 -2.62 -0.46 -16.88 -14.35 3.70 7.14
CFO/OP -287% 40% 88% -50% -202% 228% 518%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
Debtor Days 342.16 142.99 171.11 427.34 42.34 69.18 32.05
Inventory Days 86.76 233.52 171.56 2,359.46 112.70 101.71 31.51
Days Payable 231.86 43.13 53.68 655.04 8.19 33.71 77.92
Cash Conversion Cycle 197.06 333.37 288.99 2,131.76 146.85 137.19 -14.36
Working Capital Days 310.27 260.47 132.18 292.77 194.50 187.12 77.01
ROCE % 13.86% 19.41% 4.50% 2.13% 4.55%

Insights

In beta
Jun 2018 Aug 2021
DocExa Registered Doctors
count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Mediapp Pharmacy / Retailer Network
count ・Standalone data
Makebot Online Subscriptions
count ・Standalone data
Makebot School Deployment
count ・Standalone data
Makebot Student Touchpoints
count ・Standalone data
Makebot Teachers Trained
count ・Standalone data
Mediapp Stockists
count ・Standalone data
Vodo Pharma Partners
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
55.31% 55.88% 55.88% 55.86% 55.84% 55.84% 55.84% 55.84% 55.84% 55.84% 55.84% 55.84%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.15%
44.69% 44.12% 44.13% 44.15% 44.16% 44.16% 44.16% 44.17% 44.16% 44.15% 44.15% 44.01%
No. of Shareholders 4,3815,6627,7098,71810,26111,07610,94310,87410,60710,4039,8859,279

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Aug 2021
    Transcript
    AI Summary
    PPT
  • Feb 2021
    Transcript
    AI Summary
    PPT
  • Jan 2021
    Transcript
    AI Summary
    PPT
  • Nov 2020
    Transcript
    AI Summary
    PPT
  • Sep 2020
    Transcript
    AI Summary
    PPT
  • Jun 2020
    Transcript
    AI Summary
    PPT
  • Jun 2020
    Transcript
    AI Summary
    PPT
  • Jun 2018
    Transcript
    AI Summary
    PPT
  • Apr 2018
    Transcript
    AI Summary
    PPT